| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acurx Pharmaceuticals, Inc. (ACXP) has 0 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. ACXP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 | Luci David P | President And CEO | Buy | 5,200 | $4.80 | $24,960.00 | +0.5% | -17.5% | -35.0% | |
| Nov 19, 2021 | Deluccia Robert J | Director, 10% Owner | Buy | 5,034 | $4.90 | $24,671.63 | +0.5% | -17.5% | -35.0% | |
| Jun 29, 2021 | Sailer Carl | Director | Buy | 12,500 | $6.00 | $75,000.00 | +22.6% | -28.9% | -42.0% |